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of her family members. Her daughter’s development apparently
was normal. The patient could give no information regarding
the daughter’s blood pressure, or even whether the blood pres-
sure had ever been taken.
The patient was 157 cm tall and weighed 47 kg. Her blood
pressure was 280/160 mm Hg; heart rate, 80 beats/min; respira-
tory rate, 16/min. The physical examination, with the exception
of short stature and brachydactyly, was unremarkable. Fundo-
scopic examination disclosed no hemorrhages or exudates, the
heart was not palpably enlarged, she had no cardiac murmurs,
and no bruits could be heard over any vessels.
Her blood count, urinalysis, and serum chemistries, including
electrolytes, were normal. The creatinine clearance was 76 mL/
min with a sodium, potassium, and calcium excretion of 122,
38, and 1.3 mmol/day, respectively. Plasma renin activity (PRA)
and plasma aldosterone (supine posture) were 14 ng/mL/h andCASE PRESENTATION
666 pg/mL, respectively; the urinary aldosterone excretion was
A 50-year-old female schoolteacher was referred to us for 16.7 g/day. Bilateral adrenal vein aldosterone sampling re-
the evaluation of arterial hypertension. At that time, she was vealed no lateralization. Plasma and urinary norepinephrine
taking no antihypertensive medications. The condition was diag- values were normal. The renal and adrenal ultrasound exami-
nosed when the patient was 15 years old, but no treatment was
nation was normal. An echocardiogram disclosed moderateinitiated then. At age 31, her blood pressure increased precipi-
concentric left-ventricular hypertrophy without diastolic dys-tously during her only pregnancy, which nevertheless culmi-
function and with a preserved ejection fraction. A 24-hour ambu-nated in the otherwise uncomplicated delivery of a daughter.
latory blood pressure measurement confirmed severe hyperten-Subsequently, a variety of medications were tried with only
sion; however, the nocturnal blood pressure decrease wasmodest control of blood pressure. In 1993, an extensive evalua-
preserved. The patient refused magnetic resonance imaging oftion was performed at another hospital, including renal angiog-
the posterior fossa vessels because of claustrophobia. Her bloodraphy. The patient underwent bilateral percutaneous dilation
pressure was successfully reduced with hydrochlorothiazide,of her renal arteries, but her blood pressure did not decrease.
triamterene, amlodipine, enalapril, and carvedilol. She was re-Her only complaints were occasional nausea, headache, and
ferred to the Franz Volhard Clinic for autonomic testing, butlightheadedness. She denied history of stroke, visual loss, short-
she failed to appear.ness of breath, or knowledge of cardiovascular sequelae.
Her past medical history was unremarkable, with the excep-
tion of brachydactyly. A geneticist at another university had DISCUSSION
seen her when she was 27 years old, and type E brachydactyly
Dr. Friedrich C. Luft (Head, Division of Nephrologywas diagnosed (Fig. 1). No connection between the brachydac-
tyly and hypertension was made at that time. and Hypertension, Franz Volhard Clinic, Berlin, Germany):
The patient was born in Silesia (Poland). Her mother also This patient has severe hypertension and type E brachy-
had brachydactyly, as did other members of the family. Her dactyly, a genetic condition. The physicians engaged in
brother, the sole sibling, did not have brachydactyly. Since her care considered the possibility that she has autoso-
moving to Germany, she has had no further contact with any
mal-dominant hypertension and brachydactyly as de-
scribed by Bilginturan in 1973 in a family from Turkey
[1]. Consistent with this diagnosis is the fact that she hasThe Nephrology Forum is funded in part by grants from Amgen,
Incorporated; Merck & Co., Incorporated; and Dialysis Clinic, Incorpo- type E brachydactyly, plasma renin activity and plasma
rated. aldosterone values in the high-normal range, normal cir-
culating catecholamines, and no other causes for second-Key words: aldosteronism, glucocorticoids, Liddle’s syndrome, Gor-
don’s syndrome, brachydactyly. ary hypertension [2]. There is no reason to believe that
her hypertension is associated with volume expansion 2001 by the International Society of Nephrology
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disease. He found no evidence that environmental fac-
tors were associated with hypertension, although his
sample was small. Stress, occupations, work styles, and
related variables were the same in the two groups. In-
stead, he observed that 77% of the parents of hyperten-
sive patients had developed stroke and/or heart disease,
while only 30% of parents of normotensive patients had
experienced such illnesses. He posed the hypothesis that
inheritance was responsible. To test this notion further,
he measured blood pressure in 93 siblings of his hyper-
tensive patients and in 359 siblings of his normotensive
cohort. Again, for any given age, blood pressure was
higher in the siblings of hypertensive, compared to nor-
motensive patients. He then conducted family studies
and even twin analyses and concluded that hypertension
was inherited in an autosomal-dominant fashion. Weitz’s
facts were confirmed by Robert Platt of Manchester,
who studied families, and by Søbye from Copenhagen,
Fig. 1. Roentgenogram of the patient’s hands. All metacarpals and the who measured blood pressure in relatives and controls.
phalangeal bones are shortened. In this adult the cone-shaped epiphyses Doubters of this hypothesis were Hamilton, Roberts,are not visible as in childhood; however, the residua identify this brachy-
Sowry, and Pickering, who conducted studies in threedactyly as a type E.
groups of subjects: (1) a sample of the population at
large, (2) first-degree relatives of patients with essential
hypertension, and (3) first-degree relatives of persons
or salt sensitivity. Renovascular hypertension was con- without essential hypertension. Careful matching for age
sidered in the patient for reasons that we cannot discern; and gender was performed. The investigators found that
however, bilateral stent placement failed to reduce her the frequency distribution curves of arterial pressure
blood pressure. Rather than responding well to a single gradually moved upward and spread out as age advanced.
antihypertensive agent, she requires multiple agents act- At no age was there a clear division into normal or high
ing at different sites to lower her blood pressure [3]. Also blood pressure. These results were similar to those found
notable is that despite severe hypertension, she has rela- by Francis Galton for height. Galton showed that height
tively little evidence of end-organ damage in the eyes, is inherited as a graded characteristic over the whole
the heart, or the kidneys [4]. Her family history indicates range of heights encountered. The results also intro-
an autosomal-dominant brachydactyly; unfortunately we duced the notion that elevated blood pressure is not a
have no information about the blood pressure phenotype function of one gene, but rather a host of genes, each
in her relatives. She has no contact with any family mem- contributing a small effect. Pickering was knighted for
bers from her home village, and we have not been able this and other work. I refer the reader to a marvelous
to establish contact with her daughter. Finally, we have chapter by Sir George on this and other topics related
no DNA samples from her family members and are not to hypertension [6]. Nevertheless, Wilhelm Weitz and
able to fully establish the diagnosis by means of a linkage Robert Platt were not entirely wrong, since there do
analysis. The gene for autosomal-dominant hypertension exist forms of hypertension in which only one gene is
and brachydactyly has not been cloned, so DNA samples responsible for the blood pressure elevation. Today, we
from the patient will not help us. Nevertheless, the physi- are in a position to map such genes and to determine
cians involved in her care were aware that autosomal- their function.
dominant hypertension with brachydactyly has been de- Monogenic hypertension is the bright spot in the area
scribed in families outside of Turkey and that all persons of molecular genetics of human hypertension. The prem-
with brachydactyly should have their blood pressures ise is that by elucidating the mechanisms of rare mono-
measured [5]. genic diseases, we shall come to understand mechanisms
The notion that blood pressure might be heritable is of disease applicable to primary hypertension; “treasure
not new. The first careful study of this issue was con- your exceptions,” as I have written earlier [7]. This prom-
ducted by Wilhelm Weitz in 1923, then in charge of the ise has been kept largely through the efforts and successes
outpatient department at the University of Tu¨bingen. of Lifton and colleagues, whose work has introduced us
Weitz studied 82 patients with hypertension and 267 to numerous disease mechanisms. Before returning to
normotensive patients of similar age and with similar hypertension and brachydactyly, I will review several
other forms of monogenic hypertension.complaints other than those related to cardiovascular
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Glucocorticoid-remediable aldosteronism sion, low-renin, low-aldosterone, salt-sensitive form of
hypertension, which also can feature metabolic alkalosisPatients with glucocorticoid-remediable aldosteron-
and hypokalemia. It is interesting that while the hyper-ism have an autosomal-dominant monogenic hyperten-
tension responds to either thiazide or spironolactone,sion and are usually suspected of having primary aldoste-
no abnormal steroid products are present in the urine.ronism. They have volume expansion, a salt-sensitive
Licorice and carbenoxolone contain glycyrrhetinic acid,form of hypertension, tend to have metabolic alkalosis
which inhibits the 11 -hydroxysteroid dehydrogenase,with hypokalemia, and respond to thiazide diuretics and
the enzyme responsible for converting cortisol to corti-spironolactone. The latter observation is a clinical clue
sone. In the distal renal tubule, this step is crucial forthat mineralocorticoid products might be involved. These
preventing the binding of cortisol to the mineralocorticoidpatients’ renin values are low, while the plasma and
receptor, which has the same affinity for cortisol as iturinary aldosterone values are both elevated. The pa-
does for aldosterone; by contrast, cortisone does nottients also have 18-hydroxy and 18-oxocortisol steroids,
bind to the receptor. This step protects normal individu-not normally found in appreciable amounts, in their
als from developing AME. Inhibition of 11-hydroxyste-plasma and urine. Recognizing these abnormal products
roid dehydrogenase results in AME. Interestingly, AME(an intermediate phenotype) led to solving the mystery.
also can occur as a rare, autosomal-recessive form of mo-Replacement amounts of prednisone ameliorate the hy-
nogenic hypertension. Needless to say, the 11 -hydroxy-pertension and result in the disappearance of the abnor-
steroid dehydrogenase gene, which has a renal-specificmal steroids, which gives the syndrome its name.
isoform, was a hot candidate gene for this condition. TheThe abnormal cortisol derivatives and the favorable
clinical clues that I mentioned earlier were helpful ineffects of glucocorticoid treatment suggested that inner
resolving this condition: volume-dependent, salt-sensi-cortical zones, which express the gene for 17 -hydroxy-
tive hypertension; tendency to hypokalemia and meta-lase (CYP17) and are ACTH-responsive, were the source
bolic alkalosis; low renin and low aldosterone values;of the excess mineralocorticoids. Two distinct gene prod-
responsiveness to either thiazides or spironolactone de-ucts (11 -hydroxylase and aldosterone synthase) per-
spite an absence of aldosterone or any abnormal mineral-
form the terminal steps in glucocorticoid and mineralo-
ocorticoid products; and resemblance to licorice glut-
corticoid biosynthesis, respectively. A linkage analysis tony. Mune et al solved the mystery [9]. In 8 of 9 families,
in a large pedigree localized the responsible gene to the renal-specific isoform gene for 11 -hydroxysteroid
chromosome 8, exactly at the site where the genes for dehydrogenase contained mutations that indeed rendered
11 -hydroxylase and aldosterone synthase also reside [8]. the product incapable of converting cortisol to cortisone.
This fact suggested that a chimeric gene might be responsi- Therefore, the mineralocorticoid receptor is unprotected
ble, which indeed proved to be the case. Aldosterone syn- from cortisol in these patients; cortisol occupies the min-
thase (CYP11B2) and 11-hydroxylase (CYP11B1) reside eralocorticoid receptor, and thus acts as the major endog-
on chromosome 8. In affected individuals, a chimeric enous mineralocorticoid. The fascinating possibility that
gene consisting of the promotor-regulatory region of AME might be relevant in the heterozygous state was
CYP11B1 and the structural portion of CYP11B2 is lo- raised by Li et al, who reported a patient with apparent
cated between CYP11B2 and CYP11B1. The protein mineralocorticoid hypertension at age 38 years and who
product resulting from this gene performs all reactions had a daughter with homozygous AME [10]. The patient
required for aldosterone production, thus causing ACTH- had low renin and aldosterone concentrations as well as
dependent hyperaldosteronism. Ectopic expression of a mutation in the gene for 11 -hydroxysteroid dehydro-
the chimeric protein in the inner cortical zones, which genase.
also express CYP17, permits the formation of 18-hydroxy
Liddle’s syndromeand 18-oxocortisol, the biochemical hallmarks of this type
of aldosteronism. The chimeric gene results from a miotic In 1963, Liddle described patients with autosomal-
mismatch and unequal crossing over. In all instances, the dominant monogenic hypertension who also tended to
crossover is located 5 to intron 4 of the CYP11B genes. have metabolic alkalosis with hypokalemia [11]. His pa-
Finally, suppressing steroidogenesis in the zona fascicu- tients had low renin and low aldosterone values; how-
lata and reticularis with exogenous glucocorticoids alle- ever, they did not respond to spironolactone, but thia-
viates the hypertension. zides and triamterene did reduce the blood pressure.
This observation convinced Liddle that these patients
Apparent mineralocorticoid excess probably did not have a form of mineralocorticoid ex-
Genetic apparent mineralocorticoid excess (AME) re- cess. Liddle speculated that they would have a distal
sembles the syndrome observed in persons ingesting tubular defect of increased sodium and chloride reab-
large amounts of licorice. Licorice gluttony and treat- sorption. Renal transplantation performed on a patient
with Liddle’s syndrome and renal failure cured the syn-ment with carbenoxolone both cause a volume-expan-
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drome and provided strong evidence that the problem mineralocorticoid receptor gene mutation is an activat-
ing mutation in the receptor. Hypertension worsens inresided within the kidneys rather than in an extrarenal
regulatory system [12]. Shimkets et al subsequently local- affected women during pregnancy. This interesting find-
ing suggests that progesterone occupancy of the receptorized the responsible gene of a family with Liddle’s syn-
drome to chromosome 16 and showed that the gene en- activates rather than inhibits aldosterone-like effects.
Similarly, spironolactone worsens rather than improvescodes for the  subunit of the epithelial sodium channel
(ENaC) [13, reviewed in 14]. The channel is amiloride- the blood pressure elevation in this rare but fascinating
disorder.and triamterene-sensitive; this response accounts for the
efficacy of these drugs in the syndrome. The channel re-
Autosomal-dominant hypertension with brachydactylymains inappropriately permeable even in the presence
of high salt intake, and thereby explains the salt-sensitive As I mentioned earlier, this form of monogenic hyper-
tension was first described by Bilginturan et al in 1973hypertension. Subsequently a mutation in the -subunit
of ENaC has been found that also can cause Liddle’s [1]. Affected persons have a dramatic increase in blood
pressure with age and die of stroke before age 50. Wesyndrome [15]. The molecular mechanisms of Liddle’s
syndrome involve alteration or deletion of a PY motif traveled to Turkey several years ago and, with Bilgintur-
an’s assistance, examined this kindred in detail. We ob-in the cytoplasmic tails of the  or  subunits. As a
consequence, binding by the removal protein Nedd4 fails tained blood for native DNA and were able to map the
gene to the short arm of chromosome 12 [20]. Later, into occur, the channels are not internalized for ubiquitini-
zation, and they instead remain activated on the cell Berlin, we phenotyped these subjects further. We found
that their phenotype could easily be distinguished fromsurface [16].
other monogenic hypertensive syndromes described thus
Gordon’s syndrome far. By measuring plasma renin activity and plasma aldo-
sterone supine and upright, as clinicians do to diagnoseThe one or more genes responsible for type II pseudo-
hypoaldosteronism have recently been mapped, albeit primary aldosteronism, we could conveniently exclude
these conditions [21]. In glucocorticoid-remediable aldo-not yet cloned. Type II pseudohypoaldosteronism, first
described by Gordon, features familial hyperkalemia steronism, PRA is low and aldosterone concentrations
are on the high-normal side. In Liddle’s syndrome, ap-[17]. Thiazide diuretics are highly effective in this syn-
drome, commensurate with salt sensitivity. A multilocus parent mineralocorticoid excess, Gordon’s syndrome,
and mutations in the mineralocorticoid receptor, bothlinkage analysis yielded a lod score of 8.1 for linkage to
chromosomes lq31-q42 and 17p11-q21 [18]. It is interest- PRA and aldosterone levels are low. In contrast, in auto-
somal-dominant hypertension with brachydactyly, PRAing that the chromosome 17 locus overlaps a syntenic
interval in the rat that contains a blood pressure quantita- and aldosterone values are normal.
Our phenotyping efforts showed that the patients weretive trait locus. Thus, further work on the genetics of type
II pseudohypoaldosteronism likely will lead to cloning of not salt-sensitive, had normal renin-angiotensin-aldoste-
rone and catecholamine responses, and responded to notwo additional genes that can cause hypertension.
particular form of medication [2, 3]. We had hoped that
Mineralocorticoid receptor defect our search would move us down a specific, novel mecha-
nistic path. In the meantime, our cloning efforts wereLifton’s group recently presented a new mendelian
form of hypertension caused by an activating mutation not too helpful. We did find additional families with the
syndrome to narrow the genomic area of interest, andin the mineralocorticoid receptor [19]. Using the single-
strand conformation polymorphism technique, the inves- a chromosome 12p deletion syndrome in a Japanese child
assisted us as well (Fig. 2) [22]. However, we also identi-tigators screened for mutations in the mineralocorticoid
receptor in seven unrelated patients referred for possible fied a family with type E brachydactyly without hyper-
tension, whose gene locus did not map to chromosomemonogenic hypertension. One patient had a heterozy-
gous mutation at codon 810 in the mineralocorticoid 12p. This finding indicates the presence of multiple
brachydactyly type E loci (unpublished data). Further-receptor gene that resulted in a leucine for serine substi-
tution. This residue lies in the hormone-binding domain. more, no obvious candidate genes were forthcoming. For
instance, we were able to exclude the gene for parathy-The patient’s kindred were carefully examined; the index
case had severe hypertension, as did four relatives. Four roid-hormone-related peptide (PTHrP), which we had
considered a highly attractive candidate, as the PTHrPother relatives had no hypertension. Affected persons
all exhibited the leucine for serine substitution and had homozygous gene-disrupted mouse has skeletal anoma-
lies [23]. We have completed our contig, a series of over-low plasma renin activities and low aldosterone concen-
trations. Because the phenotype resembles Liddle’s syn- lapping human chromosomal segments incorporated into
yeast (YACs), plasmids (PACs), or bacteria (BACs) anddrome, the investigators first ruled out the presence of
Liddle gene mutations. The authors speculated that the are currently pursuing other candidate genes. The sulfo-
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Fig. 2. The chromosome 12p deletion in a Jap-
anese child, the cosegregating markers from the
Turkish family with autosomal-dominant hyper-
tension and brachydactyly, and those two North
American families with the same syndrome.
nylurea receptor-2 gene, which regulates potassium chan- underlying structure [5]. In patients with essential hyper-
tension, NVC is predominantly caused by a posteriornels, and several transciption factors are on our list.
inferior cerebellar artery (PICA) loop [6]. Because of
Neurovascular contact in autosomal-dominant Bilginturan’s initial observations and our earlier findings
hypertension with brachydactyly [29], we performed magnetic resonance imaging in 27
family members (Fig. 3). To assess the strength of theVascular anomalies causing neurovascular compres-
sion elicit hyperactive cranial nerve dysfunction syn- association between NVC and autosomal-dominant hy-
pertension with brachydactyly, we performed a linkagedromes, such as trigeminal neuralgia [24]. Moreover,
intra-operative observations [25, 26], anatomic studies analysis involving the cosegregating markers identified
earlier [29]. We then tested for linkage between the[27], and magnetic resonance tomography (MRT) [28]
have demonstrated a posterior fossa “neurovascular con- hypertension-brachydactyly phenotypes and the pres-
ence of NVC. All 15 affected persons had evidence oftact anomaly” (NVC) in patients with essential hyperten-
sion. This anomaly is suspected to represent neurovascu- NVC. All had left-sided posterior cerebellar artery or
vertebral artery loops, and 6 had bilateral NVC. Nonelar compression of the ventrolateral medulla (VLM) and
the root entry zone of cranial nerves IX and X. The NVC, of the nonaffected family members had NVC. The phe-
notypes were linked with a lod score of 9.2 given a pene-which is generally left-sided in patients with essential
hypertension, consists of a looping vessel, which attaches trance of 99%.
These results led us to perform detailed autonomicto the root entry zone of a cranial nerve. The NVC
can result in a hyperactive dysfunction of the respective testing in Berlin [30]. In five young patients with mono-
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Fig. 4. Doses of phenylephrine required to raise mean blood pressure
by 12.5 mm Hg in 5 members of the Turkish family (), 6 normal control
subjects (), and in both groups after complete ganglion blockade
(“block”) with trimethaphan. Note that the discrepancy between the
two groups at baseline was markedly reduced by ganglion blockade
supporting failure of baroreflex blood pressure buffering in the Turkish
family.
Fig. 3. Magnetic resonance imaging study of posterior fossa vessels
from a member of the Turkish family with autosomal-dominant hyper-
tension and brachydactyly. The loop made by the posterior-inferior sion is not without controversy, and how such patients
cerebellar artery (PICA) on the left is clearly visible. VLM, ventrolateral
should be managed is not clear. In an uncontrolled pro-medulla.
spective study by Geiger et al, mean blood pressure
decreased after surgery to relieve NVC in five patients
by 48 hours [31]. They were followed for one year, and
genic hypertension and brachydactyly, we investigated four remained normotensive. The operative procedure
whether the hypertension was mediated through sympa- obviously requires skill but does not appear to engender
thetic activation and whether increases in sympathetic frequent complications. The vascular loop is gently mobi-
nerve traffic, vascular sensitivity, or impaired baroreflex lized and moved off of the brain stem. A pad of Teflon
buffering would contribute to the phenotype. Blood pres- is implanted to preclude further pulsatile stimulation.
sure during complete ganglionic blockade was 139/82 The internal review board that approved the Geiger
mm Hg and 90/50 mm Hg in patients and controls, re- study stipulated that the procedure could only by pre-
spectively. However, cold pressor testing, hand-grip test- sented to patients whose established hypertension could
ing, and upright posture all increased blood pressure not be controlled by four or more classes of antihyperten-
excessively. In contrast, muscle sympathetic nerve activ- sive drugs.
ity was not increased at rest or during cold pressor test- Jannetta and colleagues studied neurogenic hyperten-
ing. The dose of phenylephrine that increased systolic sion in baboons to see whether they could produce an
blood pressure 12.5 mm Hg was 8 g in patients and 135 experimental model [32]. A small balloon implanted into
g in control subjects before ganglionic blockade and the region of the ventrolateral medulla was connected
5 g in patients and 13 g in control subjects during via a catheter to a second balloon in the animal’s thoracic
ganglionic blockade (Fig. 4). These results suggested that aorta. The aortic balloon caused the balloon impinging
in patients with monogenic hypertension and radiologic on the ventrolateral medulla to pulsate. The pulsatile
evidence of NVC of the ventrolateral medulla, basal impulse, maintained over days in the baboons, was asso-
blood pressure was increased independent of autonomic ciated with an increase in blood pressure sufficient to
activity. However, sympathetic stimuli caused a substan- produce an increase in heart size.
tial increase in blood pressure. Increased sympathetic The neuroradiologic diagnosis of this syndrome has
nerve traffic or increased vascular sensitivity could not been standardized recently, allowing larger epidemio-
explain this excessive response. Instead, we suggested logic studies [33]. These studies have documented the
that the ability of the baroreflex to buffer changes in presence of NVC both in hypertensive and normotensive
vascular tone is severely impaired. Thus, the hyperten- subjects. In a recent investigation, an association be-
sion could be related to abnormal baroreceptor reflex tween NVC and hypertension could not be shown in a
function in these patients. large cohort of hypertensive persons from Berlin, Ger-
many [34]. The same investigators were unable to showThe notion that NVC could cause sustained hyperten-
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an increased frequency of NVC in young subjects with already present at birth in your affected family members,
as is the case in genetic rat models of hypertension, ora strong family history of hypertension, compared to
young subjects with no such history. However, discrepan- is the hypertension solely the result of an increase in
blood pressure with advancing age?cies in terms of NVC and hypertension do not necessarily
militate against the theoretical notion of hypertension Dr. Luft: We are not very good at measuring blood
pressure in infants. In the youngest children, blood pres-induced through pulsatile brain stem contact. After all,
renal artery stenosis can exist without causing hyperten- sure is already detectably elevated compared to expected
percentile values at two to four years of age. The progres-sion. Furthermore, publication of the DRASTIC study
on renal artery stenosis does not indicate that Goldblatt sive increase in blood pressure with advancing age favors
the vascular loop hypothesis in my view.and a host of investigators since were wrong in terms of
renal artery stenosis-induced hypertension [35]. We hope Dr. Ritz: The renin and aldosterone measurements
you showed for the Turkish family were well within thethat autonomic testing as performed here, and as being
done by other investigators, will help select those individ- normal limits. In the patient presented, however, renin
concentrations were above the upper limits of normal.uals who might benefit from surgical decompression of
the VLM [36]. Are you absolutely certain that renovascular hyperten-
sion was excluded, particularly in light of the peculiarFinally, should we suggest an operation to our Turkish
patients with autosomal-dominant hypertension and history of treatment for alleged bilateral renal artery
stenosis earlier?brachydactyly? They face a lifetime of medical treatment
in an area where such treatment is not necessarily guar- Dr. Jo¨rg Radermacher (University of Hannover, Han-
nover, Germany): We did not do angiography on thisanteed, although thus far we have been able to regularly
supply them with medication. Since they have a mono- occasion. However, I am absolutely confident in our du-
plex sonographic studies that showed patent renal arter-genic disorder, they would also permit us an opportunity
to test the vascular decompression hypothesis. They are ies without obstruction. We have considerable experi-
ence with this procedure. We attributed the high reninaware of operative interventions done for this condition
levels to stress and to our failure to achieve a stableand have expressed willingness. I have told my young
baseline state. In contrast, Dr. Luft’s measurements wereassociates that I have no intention of condoning opera-
obtained while his subjects enjoyed a clinical researchtions on their fingers, although brachydactyly also cose-
center environment. We were very interested in sendinggregates with the hypertension 100%! Instead, I have
our patient to Berlin so that additional studies, includingappointed a panel of experts: a clinical autonomic phar-
provocative maneuvers involving the renin-angiotensinmacologist, a neurosurgeon, a pediatrician, an internist-
system, could be done. Unfortunately, the patient didgeneticist, and a seasoned hypertensionologist. All five
not agree to further studies. During an earlier hospital-have been on various sides of this issue. I am eagerly
ization, our patient had renin values well within the nor-awaiting their advice.
mal range.
Dr. Arya M. Sharma (Franz Volhard Clinic, Berlin):
QUESTIONS AND ANSWERS The kidney is accepted as being the final long-term regu-
Dr. Eberhard Ritz (University of Heidelberg, Heidel- lator of blood pressure by means of the pressure-natri-
berg, Germany): Why is there such a conspicuous ab- uresis relationship. Your patients showed absolutely no
sence of end-organ damage in your Turkish patients and signs of salt sensitivity. I am curious about the pressure-
also in the patient presented today? natriuresis relationship in the Turkish patients with au-
Dr. Luft: We do not know for certain. We have gone tosomal-dominant hypertension and brachydactyly and
to great lengths looking for end-organ damage in the also would like to know whether they are relatively vol-
Turkish family. Even with fluorescein angiography, the ume contracted. You showed evidence that volume expan-
fundi of these patients were only minimally affected by sion decreased sympathetic tone in your subjects and
hypertension [4]. We failed to find even microalbuminu- ameliorated their peculiar tendency to orthostatic hyper-
ira, the left-ventricular hypertrophy is minimal despite tension. Do you believe that a high-salt diet or volume
severe hypertension, and only one patient in this family expansion actually might lower their blood pressure?
developed coronary disease [2]. That patient also had Dr. Luft: We characterized our patients with the vol-
markedly elevated Lp(a) cholesterol concentrations. Per- ume-expansion, volume-contraction protocol developed
haps it is the genetic background; in the American and at Indiana University [2]. The pressure-natriuresis rela-
Canadian families with autosomal-dominant hyperten- tionship is extremely steep in our patients, although the
sion and brachydactyly, arteriosclerotic vascular disease relationship is markedly shifted rightward. The periph-
is more common [5]. eral vascular resistance of these patients is markedly
Dr. Johannes Mann (Schwabing Hospital, Munich, elevated, and our measurements of renal blood flow
showed us that the renovascular resistance is correspond-Germany): Do you know whether the hypertension is
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ingly elevated as well. We have not tested our subjects in stroke-prone spontaneously hypertensive rats. Did
this locus provide you with any candidate genes?with chronic volume expansion or a high-salt diet to
see whether those maneuvers would lower their blood Dr. Luft: A rat chromosome 5 locus has been de-
scribed by two groups [37, 38] and the atrial and brainpressure, a phenomenon that has rarely been reported
in patients with a markedly activated renin-angiotensin natriuretic peptide genes have been suggested as candi-
dates in the rat [39]. However, this portion of rat chromo-system.
Dr. Heini Murer (University of Zurich, Zurich, Swit- some 5 is not syntenic with our critical area of interest.
Dr. John T. Harrington (Dean, Tufts Universityzerland): You mentioned the sulfonylurea receptor 2
(SUR2) gene, which is located on chromosome 12p, in School of Medicine, Boston, Massachusetts, USA): I am
particularly interested in the PICA loops. Have theseyour talk. Have you had occasion to test an agonist of
this receptor to see whether an effect on blood pressure abnormal loops been studied in patients with essential
hypertension or in patients with other diseases? I amis demonstrable?
Dr. Luft: We have not tried that strategy, although rather skeptical about this notion.
Dr. Luft: I think you have good reason to be skeptical.such studies would be interesting. The SUR2 regulates
an ATP-dependent potassium channel. We might try A small case-control study performed by our group sug-
gested that such loops occur more commonly in patientsa potassium channel opener such as pinacidyl or even
diazoxide or hydralazine. with essential hypertension, compared to patients with
secondary hypertension [28]. But Dr. Sharma and associ-Dr. Hermann Haller (University of Hannover): Have
you tried any patch-clamp studies on vascular smooth ates recently performed more extensive studies and were
not able to show that PICA loops are more common inmuscle cells to look at SUR2 regulation of potassium
channels in your patients? patients with essential hypertension than in the general,
nonhypertensive population [34]. Dr. Sharma, would youDr. Luft: We tried some patch-clump studies on fi-
broblasts from our Turkish patients but were unable to like to comment on this issue?
Dr. Sharma: One of the theories proposed to explainobtain satisfactory results. We might try isolating some
vascular smooth muscle cells by means of small biopsies how these loops cause hypertension relates to their in-
creasing sympathetic activity. However, your studies inof the buttocks, which can be done easily and relatively
painlessly. the Turkish patients suggested that sympathetic activity
was not increased in these people.Dr. Ju¨rgen Schnermann (National Institutes of Health,
Bethesda, Maryland, USA): Since you described these Dr. Luft: That is correct. Their sympathetic outflow
was not increased by microneurography, and we havebrain stem vascular abnormalities at the site of the ven-
trolateral medulla in your subjects, have you had occa- no evidence for elevated blood norepinephrine or epi-
nephrine concentrations in these patients. On the othersion to examine vasopressin release or regulation?
Dr. Luft: Indeed, we were able to do that and we hand, their baroreflex buffering of blood pressure was
markedly abnormal, and that finding is consistent withfound that vasopressin levels in response to ganglion
blockade were quite elevated. These results render sup- a central mechanism.
Dr. Radermacher: Getting back to the PICA loopport for a central mechanism of blood pressure-regula-
tory derangements. issue, I wanted to ask whether any of your patients have
been operated on. I am aware that Janetta and colleaguesDr. Schnermann: One way to pursue that matter fur-
ther might be to employ specific vasopressin antagonists reported on the results of operations on PICA loops and
effects of blood pressure [25] and that Geiger et al recentlyin these patients.
Dr. Haller: I have a question regarding stroke in reported pretty good success in lowering blood pressure
by relieving putative brain stem compression [31].these patients. Do you have any evidence that a geneti-
cally determined alteration in the cerebral blood vessels Dr. Luft: No randomized controlled studies have
been reported. None of our patients have undergone theof your patients might explain their propensity for
stroke? As you know, in stroke-prone spontaneously neurovascular decompression operation. I have set up a
committee of advisors to help me on this issue, all ofhypertensive rats, specific vascular mechanisms are pos-
tulated. whom have worked on the syndrome of autosomal-domi-
nant hypertension and brachydactyly. As I said, thisDr. Luft: We have performed computer tomography
and magnetic resonance imaging studies on a few of group comprises an internist, a pediatrician, a neurosur-
geon, a hypertension expert, and a clinical pharmacolo-our patients who had had a stroke. We found cerebral
hemorrhage as well as thrombotic ischemic lesions in gist. They have not yet recommended surgery. I person-
ally believe we should first clone the one or more genessmaller vessels, such as lacunar infarcts.
Dr. Haller: Those findings could indicate that these involved so that we can understand the mechanisms be-
fore we proceed.patients have end-organ damage only in the brain.
Dr. Mann: A gene locus has been described for stroke Dr. Harrington: I would like to get back to the short
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